High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Clinical trial NCT01941758 · COMPLETED
Trial details
- NCT number
- NCT01941758
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.